Literature DB >> 8461941

The use of monoclonal antibodies for the diagnosis and therapy of bladder cancer.

P J Russell1, J Plomley, D Raghavan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8461941     DOI： 10.1111/j.1464-410x.1993.tb15903.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  4 in total

1.  Construction and expression of single-chain Fv antibody against human bladder carcinoma.

Authors:  L Z Yu; S Xiao; H L Huang; Z Gu; F L Gu; Y L Guo
Journal:  Urol Res       Date:  1996

2.  Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.

Authors:  J Malamitsi; J Zorzos; A D Varvarigou; S Archimandritis; C Dassiou; D V Skarlos; P Dimitriou; M Likourinas; A Zizi; C Proukakis
Journal:  Eur J Nucl Med       Date:  1995-01

3.  Immunotargeting of urothelial cell carcinoma with intravesically administered Tc-99m labeled HMFG1 monoclonal antibody.

Authors:  J Malamitsi; J Zorzos; A D Varvarigou; S Archimandritis; C Dassiou; G Sivolapenko; D V Skarlos; A Serefoglou; M Lykourinas; C Proukakis
Journal:  Cell Biophys       Date:  1994

4.  Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: identification of its antigen as a neutral glycolipid.

Authors:  E A Kingsley; T E Carter; K D Barrow; P J Russell
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.